Virtue Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-6,362
| Closed | -$562K | – | 400 |
|
2021
Q4 | $562K | Sell |
6,362
-12
| -0.2% | -$1.06K | 0.08% | 260 |
|
2021
Q3 | $493K | Sell |
6,374
-122
| -2% | -$9.44K | 0.09% | 247 |
|
2021
Q2 | $542K | Buy |
6,496
+249
| +4% | +$20.8K | 0.11% | 218 |
|
2021
Q1 | $472K | Buy |
6,247
+365
| +6% | +$27.6K | 0.11% | 213 |
|
2020
Q4 | $516K | Buy |
5,882
+655
| +13% | +$57.5K | 0.13% | 198 |
|
2020
Q3 | $398K | Buy |
5,227
+1,256
| +32% | +$95.6K | 0.1% | 209 |
|
2020
Q2 | $490K | Buy |
+3,971
| New | +$490K | 0.11% | 190 |
|